Novakand Pharma AB (publ) (FRA:3EE0)

Novakand Pharma AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	22.27	46.36	45.69	95.15	106.52	55.01
Cash & Short-Term Investments	22.27	46.36	45.69	95.15	106.52	55.01
Cash Growth	-61.56%	1.47%	-51.98%	-10.68%	93.65%	364.28%
Accounts Receivable	-	-	-	-	5.28	-
Other Receivables	0.61	1.54	1.24	0.86	-	1.1
Receivables	0.61	1.54	1.24	0.86	5.28	1.1
Prepaid Expenses	0.31	1.01	0.71	0.97	-	0.28
Other Current Assets	-	-	-	2.51	-	4.79
Total Current Assets	23.19	48.91	47.64	99.49	111.8	61.17
Property, Plant & Equipment	-	-	-	0.25	0.61	0.93
Long-Term Investments	0	0	0	0	0	0
Other Intangible Assets	-	18	18	21	21	21
Other Long-Term Assets	-	-	-	-	-0	-
Total Assets	23.19	66.91	65.64	120.74	133.41	83.1
Accounts Payable	-	2.67	2.75	3.33	3.6	2.41
Accrued Expenses	1.64	1.28	14.66	6.74	6.7	3.85
Current Portion of Leases	-	-	-	-	0.13	0.34
Current Unearned Revenue	-	-	-	-	-	3.24
Other Current Liabilities	1.52	0.67	0.57	3.76	-	-
Total Current Liabilities	3.16	4.61	17.98	13.83	10.43	9.84
Long-Term Debt	-	-	-	-	-	0.45
Long-Term Leases	-	-	-	-	0.44	0.53
Other Long-Term Liabilities	0	-	-	-	-0	-
Total Liabilities	3.16	4.61	17.98	13.83	10.87	10.82
Common Stock	11.78	11.78	7.92	66.27	46.79	39.52
Additional Paid-In Capital	458.82	460.92	405.57	401.58	384.21	295.54
Retained Earnings	-450.57	-410.4	-365.83	-360.94	-308.46	-262.77
Comprehensive Income & Other	-	-	-	0	-0	-
Shareholders' Equity	20.03	62.3	47.67	106.91	122.54	72.28
Total Liabilities & Equity	23.19	66.91	65.64	120.74	133.41	83.1
Total Debt	-	-	-	-	0.57	1.32
Net Cash (Debt)	22.27	46.36	45.69	95.15	105.95	53.69
Net Cash Growth	-61.56%	1.47%	-51.98%	-10.20%	97.36%	-
Net Cash Per Share	0.18	0.40	0.57	1.64	1.89	1.48
Filing Date Shares Outstanding	121.19	121.19	81.51	79.53	56.14	47.42
Total Common Shares Outstanding	121.19	121.19	81.51	79.53	56.14	47.42
Working Capital	20.03	44.3	29.66	85.66	101.37	51.33
Book Value Per Share	0.17	0.51	0.58	1.34	2.18	1.52
Tangible Book Value	20.03	44.3	29.67	85.91	101.54	51.28
Tangible Book Value Per Share	0.17	0.37	0.36	1.08	1.81	1.08
Machinery	-	-	-	0.06	0.06	0.06

Source: S&P Global Market Intelligence. Standard template. Financial Sources.